Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.6.2 was added as the latest entry and Revision: v3.6.0 was removed from the record history. This update reflects a change to the page's revision history rather than substantive content changes.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page history now shows recruitment is closed and the revision label has been updated to v3.6.0, while the previous v3.5.5 entry was removed.SummaryDifference0.1%

- Check22 days agoChange DetectedThe revision label at the bottom updated from v3.5.4 to v3.5.5, indicating a newer release of the interface.SummaryDifference0.0%

- Check44 days agoChange DetectedA new site revision entry 'Revision: v3.5.4' appears in the history, replacing the previous 'Revision: v3.5.3'. This indicates a site update rather than a change to the study data or records.SummaryDifference0.0%

- Check65 days agoChange DetectedThis updates the ClinicalTrials.gov page’s displayed revision/version number from v3.5.2 to v3.5.3, indicating a minor site build change rather than a modification to the study record.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded a new history entry (ID 143) dated 2026-04-13 with Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.